InflaRx N.V. (IFRX) Covered Calls
You can sell covered calls on InflaRx N.V. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for IFRX (prices last updated Fri 4:16 PM ET):
| InflaRx N.V. (IFRX) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 2.24 | +0.11 | 1.63 | 2.40 | 89K | - | 0.1 |
| Covered Calls For InflaRx N.V. (IFRX) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Jan 17 | 2.5 | 0.00 | 2.40 | 0.0% | 0.0% | |
| Feb 21 | 2.5 | 0.00 | 2.40 | 0.0% | 0.0% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in the Germany and United States. Its C5a is an inflammatory mediator that is involved in the enhancement of a variety of autoimmune and other inflammatory diseases. The company's lead product candidate is IFX-1, an intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase IIb clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; to treat ANCA-associated vasculitis, a rare and life-threatening autoimmune disease; and for the treatment of pyoderma gangrenosum, a chronic inflammatory skin disorder, as well as developing IFX-1 for the treatment of oncological diseases. It also develops IFX-2 that is in pre-clinical development stage for the treatment of chronic inflammation and autoimmune diseases. InflaRx N.V. has co-development agreement with Beijing Defengrei Biotechnology Co. Ltd. The company was formerly known as Fireman B.V. and changed its name to InflaRx N.V. in 2017. InflaRx N.V. was founded in 2007 and is headquartered in Jena, Germany.
| Top 10 Open Interest For Jan 17 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | INTC covered calls | 1. | RGTI covered calls | |
| 2. | SLV covered calls | 7. | SPY covered calls | 2. | NMRA covered calls | |
| 3. | AAPL covered calls | 8. | TSLA covered calls | 3. | HUMA covered calls | |
| 4. | EEM covered calls | 9. | IWM covered calls | 4. | DLO covered calls | |
| 5. | XLF covered calls | 10. | TLT covered calls | 5. | MARA covered calls | |
Want more examples? IFGL Covered Calls | IG Covered Calls
